Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A sitewide NIH announcement about a terminology transition and related updates was removed from above the page header. The page continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-08T01:29:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T19:47:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the 403 error page for the study record.
    Difference
    1%
    Check dated 2026-10-24T19:57:47.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:16:14.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:10:02.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden message, blocking access to the study record; previously visible study-related content such as contact information, documents, and location details is no longer displayed.
    Difference
    20%
    Check dated 2026-09-19T22:25:25.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.